PAML, one of the nation’s premier medical reference laboratories and a healthcare solutions company, is pleased to announce the appointment of Dr. J. Britt Ravnan to the position of Technical Director of Molecular Genetics for PAML, LLC and PAML Ventures, effective early January.

Under the general direction of the Scientific Director, Dr. J. Britt Ravnan will act as an advisor to the Molecular Diagnostics Division on technical matters. Dr. Ravnan will assure that procedures are maintained at the highest level of molecular diagnostic testing performance, proficiency testing is in place, and testing adheres to all regulatory requirements.  She will individualize patient care using age-related concepts including knowledge of growth and development, safety needs, collection and interpretation of data, and by communicating molecular diagnostic testing results with healthcare providers that are caring for patients and their families.

With a background in clinical genetics and clinical molecular genetics spanning 20 years, Dr. Ravnan brings extensive experience directing molecular genetic and clinical cytogenetic laboratories to PAML. Prior to her current appointment, Dr. Ravnan was the medical geneticist for Invitae Corporation, located in San Francisco, CA. Through affordable, high-quality testing, Dr. Ravnan worked to increase the accessibility of genetic information to clinicians and patients while in this role. Dr. Ravnan has also held positions at PerkinElmer DNA Sequencing and Analysis Services, Signature Genomic Laboratories, and Genzyme Genetics.

“Dr. Ravnan brings vast experience directing high-volume genetic laboratories, an impressive breadth of knowledge, and a commitment to quality patient care to our company,” said Francisco R. Velázquez, M.D., S.M., President and Chief Executive Officer for PAML, LLC and PAML Ventures. "Her expertise will be invaluable in her role at PAML as we continue to innovate in field of genetic testing.”

Dr. Ravnan completed a doctorate in Genetics from Stanford, and a post-doctoral fellowship in Medical Genetics at the University of California. She is a Fellow of the American College of Medical Genetics and Genomics, and frequently lectures and speaks on clinical cytogenetics and molecular genetics.